Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Heterocyclic compounds from Sankyo act as Th1-selective immunosuppressants

March 2, 2001

Treatment of T-cell-mediated diseases with new quinazoline derivatives

Feb. 26, 2001

Nabi StaphVAX elicits antibodies against resistant S. aureus strains

Feb. 26, 2001

Improved nucleoside immunomodulators in the ICN pipeline

Feb. 22, 2001

Chlamydia polypeptide and use in DNA vaccines

Feb. 21, 2001

BASB113 polynucleotides and polypeptides for use as vaccines

Feb. 21, 2001

New tuftsin analogues more potent than the parent compound and orally active

Feb. 20, 2001

Pyrimidine-based protein tyrosine kinase inhibitors and their use described by Merck

Feb. 16, 2001

Avax subsidiary to evaluate TK suicide gene therapy technology

Feb. 9, 2001

Genome Therapeutics to identify DNA map of pathogenic organism for Wyeth Lederle Vaccines

Feb. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...